tiprankstipranks
pc:eng16

Engitix Therapeutics

21 Lombard Street London, England EC3V 9AH, GB
https://www.engitix.com/
Engitix Therapeutics is a biotechnology company that discovers and develops novel therapeutics by targeting the extracellular matrix (ECM) and ECM-mediated biology. The company applies proprietary ECM proteomics and decellularized-matrix discovery platforms to identify disease-associated matrix components and to advance therapeutic candidates and biomarkers for oncology and fibrotic diseases.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$54M
Total Amount Raised$54M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$54M
Latest Funding Amount$54M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Feb 19, 2022
Series A
$54.00M

Investors

Investor Name
Funding Round

Related News and Analysis